Literature DB >> 1316461

Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.

R L Schiltz1, D S Shih, S Rasty, R C Montelaro, K E Rushlow.   

Abstract

The utilization of predicted splice donor and acceptor sites in generating equine infectious anemia virus (EIAV) transcripts in fetal donkey dermal cells (FDD) was examined. A single splice donor site identified immediately upstream of the gag coding region joins the viral leader sequence to all downstream exons of spliced EIAV transcripts. The predominant 3.5-kb transcript synthesized in EIAV-infected FDD cells appears to be generated by a single splicing event which links the leader sequence to the first of two functional splice acceptor sites near the 5' end of the S1 open reading frame (ORF). The translation products encoded by the 3.5-kb transcript were examined by producing in vitro transcripts from a cDNA corresponding to this RNA followed by in vitro translation in wheat germ extracts. These transcripts directed the synthesis of three proteins: the virus trans-activator protein (EIAV Tat) encoded by ORF S1, a protein of unknown function encoded by ORF S2, and the virus envelope glycoprotein. When transfected into FDD cells, this cDNA also directed expression of EIAV Tat. Amino-terminal sequence analysis of the in vitro-synthesized S1 protein supports the suggestion that translation of EIAV Tat is initiated at a CUG codon within the virus leader region. Both in vitro-synthesized S2 protein and synthetic peptides corresponding to S2 are shown to react positively with sera obtained from EIAV-infected horses, providing the first direct evidence of expression of this protein in infected animals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316461      PMCID: PMC241126     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.

Authors:  S Alexandersen; S Carpenter
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

Review 2.  The biochemistry of AIDS.

Authors:  Y N Vaishnav; F Wong-Staal
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

Review 3.  Human immunodeficiency virus as a prototypic complex retrovirus.

Authors:  B R Cullen
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins.

Authors:  P Dorn; L DaSilva; L Martarano; D Derse
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Pattern of transcription of the genome of equine infectious anemia virus.

Authors:  S Noiman; A Yaniv; L Sherman; S R Tronick; A Gazit
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections.

Authors:  S Rasty; B R Dhruva; R L Schiltz; D S Shih; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

7.  The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts.

Authors:  S Noiman; A Yaniv; T Tsach; T Miki; S R Tronick; A Gazit
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing.

Authors:  S Schwartz; B K Felber; G N Pavlakis
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

View more
  12 in total

1.  The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.

Authors:  F Li; C Leroux; J K Craigo; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.

Authors:  Xu Qi; Xuefeng Wang; Shuai Wang; Yuezhi Lin; Chenggang Jiang; Jian Ma; Liping Zhao; Xiaoling Lv; Rongxian Shen; Fenglong Wang; Xiangang Kong; Zhiqiang Su; Jianhua Zhou
Journal:  Virus Genes       Date:  2010-06-05       Impact factor: 2.332

3.  The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro.

Authors:  F Li; B A Puffer; R C Montelaro
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.

Authors:  Sha Jin; Charles J Issel; Ronald C Montelaro
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

5.  Identification of cellular proteins interacting with equine infectious anemia virus S2 protein.

Authors:  Lina Covaleda; Bich-Ty Gno; Fredrick J Fuller; Susan L Payne
Journal:  Virus Res       Date:  2010-04-24       Impact factor: 3.303

6.  EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages.

Authors:  Lina Covaleda; Frederick J Fuller; Susan L Payne
Journal:  Virology       Date:  2009-11-28       Impact factor: 3.616

7.  Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon.

Authors:  R Carroll; D Derse
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

8.  Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus.

Authors:  S Alexandersen; S Carpenter; J Christensen; T Storgaard; B Viuff; Y Wannemuehler; J Belousov; J A Roth
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein.

Authors:  C E Beisel; J F Edwards; L L Dunn; N R Rice
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.

Authors:  R F Cook; C Leroux; S J Cook; S L Berger; D L Lichtenstein; N N Ghabrial; R C Montelaro; C J Issel
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.